Page 1

APRIA Apria Announces Financial Results for Third Quarter 2021 November 4 , 2021 INDIANAPOLIS , Nov. 04 , 2021 ( GLOBE NEWSWIRE ) -- Apria , Inc. ( the " Company " or " Apria " ) ( Nasdaq : APR ) , a leading provider of integrated home healthcare equipment and related services in the United States , announced today financial results for the third quarter ended September 30 , 2021 . " We delivered solid third quarter 2021 financial results that were reflective of our continued execution and operational improvements building on momentum from the first half of the year , despite external headwinds . Third quarter revenue was in - line with our guidance while Adjusted EBITDA and Adjusted EBITDA less Patient Equipment Capex were at the high end or better than our forecast , " said Dan Starck , CEO of Apria . " We continue to see strong new patient volume for oxygen driven by the Delta variant which we expect to remain at elevated levels compared to historical run rates . We also continue to see elevated new patients seeking OSA treatment , and I am proud of the entire Apria team for their perseverance and commitment of effectively working with patients as we manage through the equipment shortages driven by the disruption created by the Philips recall and other supply chain challenges . " Mr. Starck continued , " In September , DM Escripts LLC announced a strategic partnership with the four national Durable Medical Equipment providers , including Apria , and two industry trade associations to drive greater use and adoption of e - Prescribe . We think wide spread adoption for e - Prescribe could be a game - changer and a meaningful driver of efficiencies and cost savings for our industry over time . Our team continues to perform at a high level providing the highest level of quality care for our patients despite the significant disruption caused by the Recall and supply chain issues and I remain confident that Apria will be able to finish the year on a high note . " Third Quarter 2021 Financial Highlights Comparisons are to the three months ended September 30 , 2020 . • Net revenue of $ 287.2 million , up 3.8 % compared to $ 276.8 million • Net Income of $ 22.8 million , or $ 0.60 per diluted share , up 300.1 % from $ 5.7 million • Adjusted EBITDA of $ 61.0 million , down 6.2 % compared to $ 65.0 million • Adjusted EBITDA less Patient Equipment Capex of $ 38.9 million , up 0.9 % from $ 38.6 million 2021 Financial Guidance For the fourth quarter of 2021 , Apria is currently projecting the following financial results : • Net revenue of $ 282 million to $ 298 million • Adjusted EBITDA of $ 54 million to $ 60 million • Adjusted EBITDA less Patient Equipment Capex of $ 27 million to $ 31 million For the full year 2021 , Apria is increasing revenue and Adjusted EBITDA guidance while narrowing the Adjusted EBITDA less Patient Equipment Capex guidance range and is now projecting the following financial results : • Net revenue of $ 1.13 billion to $ 1.15 billion ; up from $ 1.12 billion to $ 1.15 billion • Adjusted EBITDA of $ 228 million to $ 234 million ; up from $ 221 million to $ 231 million Adjusted EBITDA less Patient Equipment Capex of $ 135 million to $ 139 million ; revised from $ 132 million to $ 142 million Third Quarter 2021 Earnings Conference Call Apria will host a conference call to discuss third quarter 2021 results on November 4 , 2021 at 5:00 p.m. Eastern Time . The conference call can be accessed by dialing ( 833 ) 362-0207 for U.S. participants or ( 914 ) 987-7676 for international participants , and referencing conference ID 4161279 ; or via a live audio webcast that will be available online at https://ir.apria.com/ . A replay of the call will be available via webcast for on - demand listening shortly after the completion of the call , at the same web link , and will remain available for approximately 90 days . About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States . The Company offers a comprehensive range of products and services for in - home care and delivery across three core service lines : ( 1 ) home respiratory therapy ( including home oxygen and non - invasive ventilation ( " NIV " ) services ) ; ( 2 ) obstructive sleep apnea ( " OSA " ) treatment ( including continuous positive airway pressure ( " CPAP " )